RAB22A and hepatocellular carcinoma: Previously identified targets of miR-193b are limited, but include cyclinD1 and ETS1 in hepatoma cells55, uPA, HSP40 and RAB22A in MDA-MB-231 cells39,52 and MCL-1 in MCF7 cells72.